Mintz Levin Completes More than $7 Billion in Corporate Transactions on Behalf of Clients in 2005
1/25/2006
Boston, MA - Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. completed more than $7 billion in corporate transactions on behalf of clients in 2005, the firm announced today. Underscoring a breadth and depth of expertise, the firm handled more than 60 merger and acquisition deals, totaling more than $2.7 billion; more than 20 public securities offerings, totaling nearly $4.4 billion; and 60 venture capital deals, totaling more than $485 million.
"The level of activity we experienced in 2005, particularly in the biotech and pharmaceutical industries, is a testament to the strength of our team across the firm and long tradition of providing outstanding service to clients," said Steve Rosenthal, Co-Managing Member of the Firm. "The numbers are even more impressive, as they do not reflect the numerous other transactions with which the firm was involved."
Among the companies that Mintz Levin represented in transactions are:
- Coley Pharmaceutical Group in its IPO and concurrent placement with Pfizer, Inc. Total proceeds from the IPO and private placement were approximately $120 million, before commissions and expenses, with net proceeds at approximately $111.0 million.
- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) in its merger with Eyetech Pharmaceuticals.
- International Shipping Enterprises in its acquisition of Navios Maritime Holdings, Inc. in a transaction valued at $600 million.
- Manulife Financial Corporation and John Hancock Life Insurance Company in a securities offering through a medium-term note program totaling $2.4 billion.
- Energy XXI in a private placement in conjunction with listing on AIM Market of London Stock Exchange in a transaction totaling $300 million.
- Alinea Pharmaceuticals Inc. in a venture capital transaction totaling $27 million.
Mintz Levin is an AmLaw 100 law firm with offices in the US and the UK. The firm has exceptional depth in a broad range of practice areas, but our clients recognize that what sets us apart from other law firms is our industry focus. By truly understanding business drivers and industry trends, we are able to provide our clients with more than just legal advice. We provide legal solutions to our clients' business issues. Since 1933, our lawyers have represented entrepreneurs, emerging growth companies, government agencies, and leaders in primary industries that include Life Sciences/Biotechnology; Technology & Communications; Financial Services & Insurance; Healthcare; Real Estate, Hospitality & Construction; and Retail & Consumer Products. Our practical knowledge combined with our industry expertise enables us to provide our clients with enterprise legal advice that gives their business a competitive advantage in the marketplace.
